MOBILion takes in $60m Series C

MOBILion Systems Inc, a provider of instrumentation for biomarker discovery, diagnostics and biotherapeutic drug characterization, has raised $60 million in Series C financing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this